MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
An interventional perspective.
By Gary Siskin, MD
Gastric Embolization to Treat Obesity
The rationale behind this therapeutic option for obese patients.
By Michael Wolf, MD; Susie Park, MD; and Gary Siskin, MD, FSIR
Chronic Cerebrospinal Venous Insufficiency in Multiple Sclerosis Patients
There is speculation that CCSVI may contribute to the symptoms experienced by MS patients, but what do the data tell us so far?
By Gary Siskin, MD; Kenneth Mandato, MD; and Meridith Englander, MD
Chief Medical Editor's Page
The Many Facets of Venous Disease
By Barry T. Katzen, MD
The Venous Challenge
Merit Medical’s Siege Vascular Plug Launched in United States
October 30, 2024—Merit Medical Systems, Inc. recently announced the United States launch of its Siege vascular plug, which received FDA 510(k) clearance earlier this year.
Sirtex Medical Launches Lava Liquid Embolic System
October 27, 2023—Sirtex Medical announced the commercial availability of the Lava liquid embolic system (LES), which is approved for the treatment of peripheral vascular hemorrhage.
Merit Medical Introduces Siege Vascular Plug and Bearing nsPVA Express Prefilled Syringe
May 17, 2024—Merit Medical Systems, Inc. recently announced FDA 510(k) clearance for its Siege vascular plug.
Embolization: Delivering Results
By Jafar Golzarian, MD
Uterine Fibroid Embolization
Successful patient selection is difficult, but it makes all the difference.
By GARY P. SISKIN, MD
Sponsored by Medtronic
The Factors Influencing Coil Selection During Embolization Procedures
By Gary P. Siskin, MD
The MVP™ Microvascular Plug
A valuable addition to the armamentarium for peripheral embolization.
By Anuj Malhotra, MD, and Gary P. Siskin, MD
SIR Panel Addresses Research Needs for Interventional Treatment of CCSVI in MS Patients
June 16, 2011—The Society of Interventional Radiology (SIR) announced the publication of proceedings from a multidisciplinary research consensus panel that was charged with developing a research agenda for evaluating imaging and interventional therapies for chronic cerebrospinal venous insufficiency (CCSVI) in patients with multiple sclerosis (MS).
Studies of Interventional Treatments for CCSVI and MS Presented at SIR
March 28, 2011—The Society of Interventional Radiology (SIR) announced that Kenneth Mandato, MD, presented findings from a retrospective study of 231 multiple sclerosis (MS) patients (age range, 25–70 years; 147 women, 84 men) who underwent angioplasty of the internal jugular and azygous veins with or without placement of a stent to improve MS-related symptoms.
Interventional Treatments of Multiple Sclerosis Studied
Relative No-Stent Zones in the Femoropopliteal Arteries
Technological considerations for the infrainguinal arterial bed from one cardiology-based team.
By Gary M. Ansel, MD, FACC; Charles F. Botti Jr, MD, FACC; and Mitchell J. Silver, DO, FACC
Vascular Access Surveillance With Angioplasty: A Halfway Technology?
The role of access surveillance combined with angioplasty to achieve the goal of reducing vascular access thrombosis and prolonging access survival in hemodialysis patients.
By Jack Work, MD
